In vitro and in vivo antitumor activity of the NF-κB inhibitor DHMEQ in the human T-cell leukemia virus type I-infected cell line, HUT-102

This publication has 19 references indexed in Scilit:

• A novel NF-?B inhibitor DHMEQ selectively targets constitutive NF-?B activity and induces apoptosis of multiple myeloma cellsin vitro andin vivo
  International Journal of Cancer, 2004
• Tax-Independent Constitutive IκB Kinase Activation in Adult T-Cell Leukemia Cells
  Neoplasia, 2004
• Inhibition of Tumor Necrosis Factor-α-induced Nuclear Translocation and Activation of NF-κB by Dehydroxymethylepoxyquinomicin
  Journal of Biological Chemistry, 2002
• Bay 11-7082 inhibits transcription factor NF-kappa B and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells
  Blood, 2002
• Synthesis of NF-κB activation inhibitors derived from epoxyquinomicin C
  Bioorganic & Medicinal Chemistry Letters, 2000
• Persistent activation of NF-κB by the Tax transforming protein of HTLV-1: hijacking cellular IκB kinases
  Oncogene, 1999
• Complementation Cloning of NEMO, a Component of the IκB Kinase Complex Essential for NF-κB Activation
  Cell, 1998
• Epoxyquinomicins A, B, C and D, New Antibiotics from Amycolatopsis. II. Effect on Type II Collagen-induced Arthritis in Mice.
  The Journal of Antibiotics, 1997
• Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.
  Proceedings of the National Academy of Sciences, 1981
• Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma
  Proceedings of the National Academy of Sciences, 1980